Endothelin‐1 receptor blockade as new possible therapeutic approach in multiple myelomaAnna Russignan(University of Verona), Cristina Tecchio(University of Verona)British Journal of HaematologyJune 9, 201710.1111/bjh.14771Cited by 21SaveCiteExport RISWatch citationsRelated PapersLong-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy|Haematologica|2024|4